Metraipolis › archive › dc_c207f7ae7162

Dacomitinib as a First-Line Therapy for Advanced EGFR-Mutated Non-Small Cell Lung Cancer Without Brain Metastases: A Multicenter Retrospective Observational… — Europe PMC PMID:41761381

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41761381
DOI
10.1002/cam4.71659
License (as archived)
solo-consultazione
Archived
2026-11-05T11:17:13.154Z
SHA-256 of the archived text
27a89d8ec57b5c25b75ffe8794f52755ad74d164c2409bd2e8dcebe7a2f31c0a
Stable URL of this page
https://metraipolis.com/documento/dc_c207f7ae7162

How to cite

Dacomitinib as a First-Line Therapy for Advanced EGFR-Mutated Non-Small Cell Lung Cancer Without Brain Metastases: A Multicenter Retrospective Observational… — Europe PMC PMID:41761381 — Europe PMC (en), https://europepmc.org/article/MED/41761381 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c207f7ae7162 (Metraipolis archive dc_c207f7ae7162, sha256 27a89d8ec57b5c25b75ffe8794f52755ad74d164c2409bd2e8dcebe7a2f31c0a)
BibTeX
@misc{dcc207f7ae7162,
  title = {Dacomitinib as a First-Line Therapy for Advanced EGFR-Mutated Non-Small Cell Lung Cancer Without Brain Metastases: A Multicenter Retrospective Observational… — Europe PMC PMID:41761381},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41761381},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c207f7ae7162; sha256 27a89d8ec57b5c25b75ffe8794f52755ad74d164c2409bd2e8dcebe7a2f31c0a},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41761381. Agents can read the archived copy with the MCP tool read_document.